Tbo-filgrastim (Granix)

This slideshow reviews Tbo-filgrastim (Granix), indicated for reduction in the duration of severe neutropenia in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with febrile neutropenia.